Adage Capital Partners Gp, L.L.C. Milestone Pharmaceuticals Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $59.7 Billion
- Q3 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 6,976,000 shares of MIST stock, worth $14.4 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
6,976,000Holding current value
$14.4 Million% of portfolio
0.02%Shares
5 transactions
Others Institutions Holding MIST
# of Institutions
68Shares Held
38.4MCall Options Held
111KPut Options Held
270K-
Propel Bio Management, LLC Los Angeles, CA5.12MShares$10.6 Million10.26% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$10.2 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.22MShares$6.64 Million0.22% of portfolio
-
Morgan Stanley New York, NY2.97MShares$6.12 Million0.0% of portfolio
-
Simplify Asset Management Inc. New York, NY2.83MShares$5.84 Million0.32% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $61.8M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...